QINGDAO GLYCOGENE PHARMACEUTICAL TECHNOLOGY CO LTD

Overview

QINGDAO GLYCOGENE PHARMACEUTICAL TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 14 active FDA Type II Drug Master Files, covering 2'-OME-G(IBU)-3'-PHOSPHORAMIDITE; 5'-O-(4,4'-DIMETHOXYTRITYL)-2'-DEOXY-2'-FLUOROURIDINE-3'-(2-CYANOETHYL-N,N-DIISOPROPYL)PHOSPHORAMIDITE; 5'-O-DMT-2'-FLUORO-N2-ISOBUTYRYL-2'-DEOXYGUANOSINE 3'-CE PHOSPHORAMIDITE; 5'-O-DMT-2'-O-METHYLURIDINE 3'-CE- PHOSPHORAMIDITE; 5'-O-DMT-N4-ACETYL-2'-FLUORO-2'-DEOXY-CYTIDINE 3'-CE PHOSPHORAMIDITE; ADENOSINE-5'-TRIPHOSPHATE, TRISODIUM SALT (100mM).

API / Drug Master Files

QINGDAO GLYCOGENE PHARMACEUTICAL TECHNOLOGY CO LTD holds 14 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • M7G(5')PPP(5')(2'OMEA)PGActive2026-02-03
  • 2'-OME-G(IBU)-3'-PHOSPHORAMIDITEActive2024-07-24
  • 5'-O-DMT-2'-FLUORO-N2-ISOBUTYRYL-2'-DEOXYGUANOSINE 3'-CE PHOSPHORAMIDITEActive2024-07-24
  • 5'-O-DMT-N4-ACETYL-2'-FLUORO-2'-DEOXY-CYTIDINE 3'-CE PHOSPHORAMIDITEActive2024-07-09
  • N-ACETYL-5'-O(4,4-DIMETHOXYTRITYL)-2'-O-METHYLCYTIDINE- 3'-(2-CYANOETHYL-N,N DIISOPROPYL)PHOSPHORAMIDITEActive2024-07-08
  • N-BENZOYL-5'-O-(4,4'-DIMETHOXYTRITYL)-2'-O-METHYLADENOSINE-3'-(2-CYANOETHYL-N,N-DIISOPROPYL)PHOSPHORAMIDITEActive2024-06-24
  • N6-BENZOYL-2'-DEOXY-5'-O-DMT-2'-FLUOROADENOSINE 3'-CE PHOSPHORAMIDITEActive2024-06-23
  • 5'-O-(4,4'-DIMETHOXYTRITYL)-2'-DEOXY-2'-FLUOROURIDINE-3'-(2-CYANOETHYL-N,N-DIISOPROPYL)PHOSPHORAMIDITEActive2024-05-30
  • 5'-O-DMT-2'-O-METHYLURIDINE 3'-CE- PHOSPHORAMIDITEActive2024-05-27
  • M7(3'OMEG)(5')PPP(5')(2'OMEA)PGActive2024-02-05
  • GUANOSINE 5'-TRIPHOSPHATEActive2023-12-28
  • CYTIDINE 5'-TRIPHOSPHATEActive2023-12-28
  • URIDINE 5'- TRIPHOSPHATEActive2023-12-28
  • ADENOSINE-5'-TRIPHOSPHATE, TRISODIUM SALT (100mM)Active2023-12-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to QINGDAO GLYCOGENE PHARMACEUTICAL TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.